Sign Up to like & get
recommendations!
0
Published in 2018 at "Health policy"
DOI: 10.1016/j.healthpol.2017.11.012
Abstract: BACKGROUND Advanced therapy medicinal products (ATMPs) are innovative therapies likely associated with high prices. Payers need guidance to create a balance between ensuring patient access to breakthrough therapies and maintaining the financial sustainability of the…
read more here.
Keywords:
funding breakthrough;
breakthrough therapies;
based payment;
funding ... See more keywords